Gene therapy is an experimental treatment that involves introducing genetic material into a personﾒs cells to fight or prevent disease. Researchers are studying gene therapy for a number of diseases, such as severe combined immuno-deficiencies, hemophilia, Parkinson's disease, cancer and even HIV, through a number of different approaches. A gene can be delivered to a cell using a carrier known as a ﾓvector.ﾔ The most common types of vectors used in gene therapy are viruses. The viruses used in gene therapy are altered to make them safe, although some risks still exist with gene therapy. The technology is still in its infancy. According to our (Global Info Research) latest study, the global Gene Therapy market size was valued at USD 7282.5 million in 2022 and is forecast to a readjusted size of USD 37570 million by 2029 with a CAGR of 26.4% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. Global Gene Therapy key players include Biogen, Novartis, Gilead Sciences, etc. Global top three manufacturers hold a share about 75%. North America is the largest market, with a share about 60%, followed by Europe and Asia-Pacific, both have a share about 35 percent. In terms of product, Non-viral Gene Therapy is the largest segment, with a share about 55%. And in terms of application, the largest application is Neurological Diseases, followed by Cancer. This report is a detailed and comprehensive analysis for global Gene Therapy market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided. Key Features: Global Gene Therapy market size and forecasts, in consumption value ($ Million), 2018-2029 Global Gene Therapy market size and forecasts by region and country, in consumption value ($ Million), 2018-2029 Global Gene Therapy market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029 Global Gene Therapy market shares of main players, in revenue ($ Million), 2018-2023 The Primary Objectives in This Report Are: To determine the size of the total market opportunity of global and key countries To assess the growth potential for Gene Therapy To forecast future growth in each product and end-use market To assess competitive factors affecting the marketplace This report profiles key players in the global Gene Therapy market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics and Alnylam Pharmaceuticals, etc. This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence. Market segmentation Gene Therapy market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets. Market segment by Type Viral Gene Therapy Non-Viral Gene Therapy Market segment by Application Neurological Diseases Cancer Other Market segment by players, this report covers Biogen Novartis Gilead Sciences Sarepta Therapeutics Alnylam Pharmaceuticals Amgen Spark Therapeutics Akcea Therapeutics bluebird bio Sunway Biotech SIBIONO AnGes Orchard Therapeutics Human Stem Cells Institute Market segment by regions, regional analysis covers North America (United States, Canada, and Mexico) Europe (Germany, France, UK, Russia, Italy, and Rest of Europe) Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific) South America (Brazil, Argentina and Rest of South America) Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa) The content of the study subjects, includes a total of 13 chapters: Chapter 1, to describe Gene Therapy product scope, market overview, market estimation caveats and base year. Chapter 2, to profile the top players of Gene Therapy, with revenue, gross margin and global market share of Gene Therapy from 2018 to 2023. Chapter 3, the Gene Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast. Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029. Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Gene Therapy market forecast, by regions, type and application, with consumption value, from 2024 to 2029. Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War Chapter 12, the key raw materials and key suppliers, and industry chain of Gene Therapy. Chapter 13, to describe Gene Therapy research findings and conclusion.
1 Market Overview 1.1 Product Overview and Scope of Gene Therapy 1.2 Market Estimation Caveats and Base Year 1.3 Classification of Gene Therapy by Type 1.3.1 Overview: Global Gene Therapy Market Size by Type: 2018 Versus 2022 Versus 2029 1.3.2 Global Gene Therapy Consumption Value Market Share by Type in 2022 1.3.3 Viral Gene Therapy 1.3.4 Non-Viral Gene
